Page 302 - Analytical method for food addtives
P. 302

19



            E444: Sucrose acetate isobutyrate








            19.1  Introduction

            The major food groups contributing to dietary intake of sucrose acetate isobutyrate
            are cloudy soft drinks with the maximum permitted level of 300 mg/kg being
            allowed in non-alcoholic flavoured cloudy drinks. The ADI for sucrose acetate
            isobutyrate is 10 mg/kg body weight/day.
              Sucrose acetate isobutyrate (SAIB), a mixture of esters of sucrose, with a
            composition approximating the name sucrose diacetate hexaisobutyrate, has been
            used for over 30 years in many countries as a ‘weighting’ or ‘density-adjusting’
            agent in non-alcoholic carbonated and non-carbonated beverages. 1


            19.2  Methods of analysis
            The only references that could be found for sucrose acetate isobutyrate were for the
            chemical and physical properties and for toxicological information with uses as an
            additive and recommended acceptable daily intakes of this compound. No refer-
            ences could be found for its analysis in foodstuffs since 1980; however, a dated GC
                                                                        2
            method with diethyl ether extraction of soft drinks was published in 1972  and
                3
            1973 , and now recently a GC method with solid phase extraction of food additive
                                          4
            premixes has been published in 2001.  A summary of the method is given in the
            Appendix and Table 19.1, together with the matrices for which the method is
            applicable. Statistical parameters for this method are summarised in Table 19.2.

            19.3  Recommendations
                                                           4
            The recent method published for sucrose acetate isobutyrate  needs to be validated
            by collaborative trial.
   297   298   299   300   301   302   303   304   305   306   307